Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685840 · ClinicalTrials.gov registry record · NA
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 894
- Enrollment target
NCT01685840 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 894 participants.
The verdict
NCT01685840, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 894 participants
- Enrollment target
Study Summary
The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.
Interventions
- OTHER Usual Care
- DEVICE Biomarker-guided care NT-proBNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 894 participants |
| Start Date | 2012-12 |
| Est. Completion | 2016-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01685840
The ClinicalTrials.gov registry entry for NCT01685840 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 894 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01685840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01685840 about?
NCT01685840 is a clinical study titled "Guiding Evidence Based Therapy Using Biomarker Intensified Treatment". The primary objective is to determine the efficacy of a strategy of biomarker-guided therapy compared with usual care in high risk patients with left ventricular systolic dysfunction.
What is the current status of trial NCT01685840?
This trial is currently terminated. It is a NA study. The enrollment target is 894 participants. The study started on 2012-12. Estimated completion is 2016-09-20.
What interventions are being tested in trial NCT01685840?
The interventions under investigation include: Usual Care (OTHER), Biomarker-guided care NT-proBNP (DEVICE).
Who is sponsoring clinical trial NCT01685840?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.